These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 24332516)
1. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC; Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516 [TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751 [TBL] [Abstract][Full Text] [Related]
3. The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma. Ozolins M; Williams HC; Armstrong SJ; Bath-Hextall FJ Trials; 2010 Apr; 11():42. PubMed ID: 20409337 [TBL] [Abstract][Full Text] [Related]
4. Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial. Williams HC; Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PSJ; J Invest Dermatol; 2017 Mar; 137(3):614-619. PubMed ID: 27932240 [TBL] [Abstract][Full Text] [Related]
5. What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial. Tinelli M; Ozolins M; Bath-Hextall F; Williams HC BMC Dermatol; 2012 Oct; 12():19. PubMed ID: 23035730 [TBL] [Abstract][Full Text] [Related]
6. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study. van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074 [TBL] [Abstract][Full Text] [Related]
7. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150 [TBL] [Abstract][Full Text] [Related]
8. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage. Neville JA; Williford PM; Jorizzo JL J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal. Lecluse LL; Spuls PI Br J Dermatol; 2015 Jan; 172(1):8-10. PubMed ID: 25581584 [TBL] [Abstract][Full Text] [Related]
10. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study. Vun Y; Siller G Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. Roozeboom MH; Nelemans PJ; Mosterd K; Steijlen PM; Arits AH; Kelleners-Smeets NW Br J Dermatol; 2015 Mar; 172(3):739-45. PubMed ID: 25066012 [TBL] [Abstract][Full Text] [Related]
12. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma. Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733 [TBL] [Abstract][Full Text] [Related]
13. Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream. Ezughah FI; Affleck AG; Evans A; Ibbotson SH; Fleming CJ J Dermatolog Treat; 2008; 19(3):156-8. PubMed ID: 18569271 [TBL] [Abstract][Full Text] [Related]
14. Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks. Quirk C; Gebauer K; Owens M; Stampone P Australas J Dermatol; 2006 Nov; 47(4):258-65. PubMed ID: 17034468 [TBL] [Abstract][Full Text] [Related]
15. Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial. Sinx KAE; Nelemans PJ; Kelleners-Smeets NWJ; Winnepenninckx VJL; Arits AHMM; Mosterd K J Am Acad Dermatol; 2020 Aug; 83(2):469-476. PubMed ID: 32320773 [TBL] [Abstract][Full Text] [Related]
16. Imiquimod 5% cream as an adjuvant pre-operative treatment for basal cell carcinoma of the periocular area. Bonilla R; Solebo AL; Khandwala MA; Jones CA Orbit; 2014 Dec; 33(6):471-3. PubMed ID: 25255050 [TBL] [Abstract][Full Text] [Related]
17. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. Vidal D; Matías-Guiu X; Alomar A Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339 [TBL] [Abstract][Full Text] [Related]
18. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience. Tillman DK; Carroll MT Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590 [TBL] [Abstract][Full Text] [Related]
19. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma. Shulstad RM Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375 [TBL] [Abstract][Full Text] [Related]
20. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. Marks R; Gebauer K; Shumack S; Amies M; Bryden J; Fox TL; Owens ML; J Am Acad Dermatol; 2001 May; 44(5):807-13. PubMed ID: 11312429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]